NASDAQ : TVGN
Tevogen Bio Holdings Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 5.9 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 92.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 10.62M | 15.88M | 23.43M | 4.44M | 8.43M | 1.66M |
| Research & Development | 10.78M | 10.26M | 30.14M | 4.40M | 5.29M | 2.96M |
| Operating Expenses | 21.40M | 26.14M | 53.56M | 8.84M | 13.72M | 4.62M |
| Operating Income | -21.40M | -26.14M | -53.56M | -8.84M | -13.72M | -4.62M |
| Interest Expense | -302.57K | -195.62K | -184.04K | -1.21M | -933.08K | -599.17K |
| Interest & Investment Income | 345.00 | 663.00 | 664.00 | |||
| Other Non Operating Income (Expenses) | 92.91K | 60.70K | -948.18K | |||
| EBT Excluding Unusual Items | -21.61M | -26.28M | -54.70M | -10.05M | -14.66M | -5.22M |
| Merger & Restructuring Charges | -7.50M | |||||
| Other Unusual Items | 48.47M | -50.43M | -7.38M | -10.38M | ||
| Pretax Income | -21.61M | -26.28M | -13.73M | -60.48M | -22.04M | -15.60M |
| Net Income | -21.61M | -26.28M | -13.73M | -60.48M | -22.04M | -15.60M |
| Preferred Dividends & Other Adjustments | 627.84K | 550.00K | -3.45M | |||
| Net Income to Common | -22.24M | -26.83M | -10.27M | -60.48M | -22.04M | -15.60M |
| Shares Outstanding (Basic) | 3.52M | 3.32M | 2.93M | 495.04K | 505.07K | 501.60K |
| Shares Outstanding (Diluted) | 3.52M | 3.32M | 2.93M | 495.04K | 505.07K | 501.60K |
| EPS (Basic) | -6.32 | -8.08 | -3.50 | -122.17 | -43.64 | -31.09 |
| EPS (Diluted) | -6.32 | -8.08 | -3.50 | -122.17 | -43.64 | -31.09 |
| Free Cash Flow | -11.63M | -12.39M | -12.00M | -8.30M | -9.13M | -5.38M |
| Free Cash Flow Per Share | -3.31 | -3.73 | -4.09 | -16.77 | -18.09 | -10.73 |
| EBITDA | -21.28M | -25.95M | -53.40M | -8.68M | -13.63M | -4.61M |
| D&A For EBITDA | 119.11K | 190.57K | 162.21K | 163.30K | 90.44K | 9.38K |
| EBIT | -21.40M | -26.14M | -53.56M | -8.84M | -13.72M | -4.62M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.08M | 552.37K | 1.28M | 1.05M | 5.48M | 7.12M |
| Cash & Short-Term Investments | 1.08M | 552.37K | 1.28M | 1.05M | 5.48M | 7.12M |
| Other Receivables | 158.82K | 158.82K | 158.82K | |||
| Receivables | 158.82K | 158.82K | 158.82K | |||
| Prepaid Expenses | 768.29K | 828.59K | 919.09K | 670.58K | 352.98K | 53.96K |
| Total Current Assets | 2.01M | 1.54M | 2.36M | 1.72M | 5.84M | 7.17M |
| Property, Plant & Equipment | 1.47M | 1.59M | 524.93K | 928.51K | 1.31M | 142.62K |
| Long-Term Deferred Charges | 178.01K | 183.55K | 2.58M | |||
| Other Long-Term Assets | 1.07M | 1.07M | 575.84K | 271.14K | 594.88K | 342.65K |
| Total Assets | 4.73M | 4.38M | 3.46M | 5.51M | 7.74M | 7.66M |
| Accounts Payable | 2.83M | 3.34M | 5.20M | 3.42M | 865.91K | 378.00K |
| Accrued Expenses | 1.21M | 1.42M | 1.56M | 976.30K | 578.77K | 244.68K |
| Short-Term Debt | 1.65M | 1.65M | 1.65M | |||
| Current Portion of Long-Term Debt | 80.71M | |||||
| Current Portion of Leases | 327.74K | 327.74K | 229.06K | 252.71K | 278.21K | |
| Other Current Liabilities | 133.90K | 331.09K | 403.23K | 120.15K | 237.60K | 45.27K |
| Total Current Liabilities | 6.15M | 7.07M | 9.04M | 85.48M | 1.96M | 667.94K |
| Long-Term Debt | 6.40M | 4.40M | 1.00M | 14.22M | 39.30M | 23.48M |
| Long-Term Leases | 1.06M | 1.12M | 5.80K | 234.86K | 432.73K | |
| Other Long-Term Liabilities | 1.82K | 26.48K | 87.18K | |||
| Total Liabilities | 13.62M | 12.62M | 10.14M | 99.93M | 41.69M | 24.15M |
| Common Stock | 426.00 | 402.00 | 356.00 | 12.00K | 61.88K | 63.88K |
| Additional Paid-In Capital | 133.18M | 122.63M | 97.91M | 5.22M | 5.17M | 586.23K |
| Retained Earnings | -150.87M | -139.66M | -113.39M | -99.66M | -39.18M | -17.14M |
| Total Common Equity | -17.69M | -17.03M | -15.47M | -94.43M | -33.95M | -16.49M |
| Shareholders' Equity | -8.89M | -8.23M | -6.67M | -94.43M | -33.95M | -16.49M |
| Total Liabilities & Equity | 4.73M | 4.38M | 3.46M | 5.51M | 7.74M | 7.66M |
| Total Debt | 9.44M | 7.50M | 2.89M | 95.42M | 40.01M | 23.48M |
| Net Cash (Debt) | -8.36M | -6.95M | -1.60M | -94.37M | -34.52M | -16.36M |
| Net Cash Per Share | -2.38 | -2.09 | -0.55 | -190.63 | -68.35 | -32.62 |
| Filing Date Shares Outstanding | 6.51M | 4.16M | 3.68M | 3.29M | 24.75M | 501.60K |
| Total Common Shares Outstanding | 4.26M | 4.02M | 3.56M | 24.75M | 24.75M | 501.60K |
| Working Capital | -4.14M | -5.53M | -6.68M | -83.76M | 3.88M | 6.51M |
| Book Value Per Share | -4.16 | -4.24 | -4.35 | -3.81 | -1.37 | -32.87 |
| Tangible Book Value | -17.69M | -17.03M | -15.47M | -94.43M | -33.95M | -16.49M |
| Tangible Book Value Per Share | -4.16 | -4.24 | -4.35 | -3.81 | -1.37 | -32.87 |
| Machinery | 458.55K | 458.55K | 458.55K | 458.55K | 152.00K | |
| Leasehold Improvements | 126.28K | 263.22K | 263.22K | 263.22K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.61M | -26.28M | -13.73M | -60.48M | -22.04M | -15.60M |
| Depreciation & Amortization | 232.21K | 509.20K | 403.58K | 378.36K | 230.82K | 9.38K |
| Other Amortization | 799.99K | |||||
| Stock-Based Compensation | 11.83M | 16.22M | 40.76M | 4.58M | 582.41K | |
| Other Operating Activities | -92.91K | -60.70K | -40.23M | 51.63M | 8.32M | 10.98M |
| Change in Accounts Payable | -1.52M | -1.96M | 1.69M | 1.11M | 354.91K | -1.09M |
| Change in Other Net Operating Assets | -410.70K | -760.38K | -1.69M | -821.06K | -96.92K | -156.34K |
| Operating Cash Flow | -11.57M | -12.33M | -12.00M | -8.17M | -8.66M | -5.27M |
| Capital Expenditures | -64.44K | -64.44K | -133.00K | -479.04K | -109.73K | |
| Investing Cash Flow | -64.44K | -64.44K | -133.00K | -479.04K | -109.73K | |
| Long-Term Debt Issued | 3.40M | 1.00M | 4.00M | 7.50M | 12.50M | |
| Net Debt Issued (Repaid) | 2.00M | 3.40M | 1.00M | 4.00M | 7.50M | 12.50M |
| Issuance of Common Stock | 7.16M | 8.36M | ||||
| Other Financing Activities | 2.87M | -100.00K | 229.33K | -127.75K | ||
| Financing Cash Flow | 12.03M | 11.66M | 12.23M | 3.87M | 7.50M | 12.50M |
| Net Cash Flow | 396.93K | -730.62K | 230.60K | -4.43M | -1.63M | 7.12M |
| Free Cash Flow | -11.63M | -12.39M | -12.00M | -8.30M | -9.13M | -5.38M |
| Free Cash Flow Per Share | -3.31 | -3.73 | -4.09 | -16.77 | -18.09 | -10.73 |
| Levered Free Cash Flow | -3.05M | -1.77M | 10.62M | -3.52M | -4.11M | |
| Unlevered Free Cash Flow | -2.86M | -1.65M | 10.73M | -2.77M | -3.53M | |
| Change in Working Capital | -1.93M | -2.72M | -5.49K | 293.20K | 257.99K | -1.25M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 87.97M | 65.79M | 180.30M | 176.04M | 495.15M | |
| Enterprise Value | 96.33M | 81.08M | 187.74M | 266.94M | ||
| Last Close Price | 5.90 | 16.55 | 51.50 | 556.50 | 516.50 | |
| PB Ratio | -7.99 | -27.02 | -1.86 | -14.58 | ||
| Debt / Equity Ratio | -1.06 | -0.91 | -0.43 | -1.01 | -1.18 | -1.42 |
| Net Debt / Equity Ratio | -0.94 | -0.84 | -0.24 | -1.00 | -1.02 | -0.99 |
| Net Debt / EBITDA Ratio | -0.39 | -0.27 | -0.03 | -10.87 | -2.53 | -3.55 |
| Net Debt / FCF Ratio | -0.72 | -0.56 | -0.13 | -11.36 | -3.78 | -3.04 |
| Quick Ratio | 0.20 | 0.10 | 0.16 | 0.01 | 2.80 | 10.66 |
| Current Ratio | 0.33 | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
| Return on Assets (ROA) | -297.37% | -416.53% | -746.67% | -83.46% | -111.41% | |
| Return on Capital Employed (ROCE) | 1,504.20% | 973.40% | 959.80% | 11.10% | -237.50% | -66.10% |
| Earnings Yield | -113.08% | -39.94% | -7.61% | -34.36% | -4.45% | |
| FCF Yield | -13.27% | -18.84% | -6.65% | -4.72% | -1.85% | |
| Buyback Yield / Dilution | -13.23% | -13.17% | -492.57% | 1.98% | -0.69% |